The use of base editing in stem-cell based therapies
Drug Discovery World
JANUARY 23, 2023
Increasing interest in CRISPR-Cas gene editing systems over recent years has delivered innovative developments in precision genome engineering technologies, holding enormous potential for applications across the healthcare sector. The first in-person iPSC-derived regenerative therapy trial took place at Kyoto University, Japan.
52 
Let's personalize your content